Itatsu Keita, Fujii Takahiko, Sasaki Motoko, Zen Yoh, Nakanuma Yasuni
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa 920-8640, Japan.
Hepatogastroenterology. 2007 Apr-May;54(75):677-80.
Intrabiliary metastasis of colorectal carcinoma is not infrequent. We demonstrated interesting intraductal biliary epithelial lesions in two cases of colorectal carcinoma. The first case (65-year-old female) presented intrahepatic papillary adenocarcinoma with intrabiliary extension. While this biliary carcinoma was once diagnosed as intrabiliary metastasis of colon carcinoma, these carcinoma cells were positive for cytokeratin 7 (CK7, biliary cytokeratin) and negative for CK20 (intestinal cytokeratin). In addition, these carcinoma cells were oncocytic. Finally, a diagnosis of intraductal papillary cholangiocarcinoma of oncocytic variant was made. In the second case (74-year-old male), atypical biliary epithelial lesions were found near intrabiliary metastasis of colon carcinoma. The atypical lesions were immunohistochemically positive for CK7 but negative for CK20, and negative for p53. On the contrary, intraductal metastatic carcinoma was totally reversed, suggesting that atypical biliary lesions were not metastatic. Survey of such atypical biliary lesions in 6 consecutive cases with intrabiliary metastasis from colon carcinoma including this case disclosed that one third of such cases revealed such atypical biliary lesions. A variable type of biliary lesions should be carefully differentiated from intrabiliary metastatic colorectal carcinoma and a combined immunohistochemistry of CK7 and CK20 is useful for this differentiation.
结直肠癌的胆管内转移并不少见。我们在两例结直肠癌患者中发现了有趣的胆管内胆管上皮病变。第一例(65岁女性)表现为肝内乳头状腺癌伴胆管内浸润。虽然这种胆管癌曾被诊断为结肠癌的胆管内转移,但这些癌细胞细胞角蛋白7(CK7,胆管细胞角蛋白)呈阳性,而细胞角蛋白20(肠细胞角蛋白)呈阴性。此外,这些癌细胞为嗜酸性细胞。最后,诊断为嗜酸性细胞变异型胆管内乳头状胆管癌。第二例(74岁男性)在结肠癌的胆管内转移灶附近发现了非典型胆管上皮病变。这些非典型病变免疫组化显示CK7阳性,但CK20阴性,p53阴性。相反,胆管内转移癌完全相反,提示非典型胆管病变并非转移性病变。对包括该病例在内的6例连续的结肠癌胆管内转移患者的此类非典型胆管病变进行调查发现,其中三分之一的病例存在此类非典型胆管病变。应仔细区分各种类型的胆管病变与胆管内转移性结直肠癌,联合应用CK7和CK20免疫组化有助于这种鉴别。